
Yale researchers just graded the entire anti-aging industry, and most supplements failed the test.
Quick Take
- Yale scientists reviewed 51 human studies testing drugs, diets, and lifestyle changes against 111 aging biomarkers.
- Exercise paired with a healthy diet consistently lowered epigenetic age scores.
- Prescription drugs like metformin, semaglutide, and anti-inflammatory therapies showed the biggest marker drops.
- Most over-the-counter supplements showed little to no measurable effect.
- The study measured biological markers, not actual lifespan, so no one can yet claim these interventions add years to your life.
Yale Built A Scorecard For Anti-Aging Claims
Researchers at Yale School of Medicine pulled together 51 longitudinal human studies and checked them against 111 different DNA-methylation biomarkers, including 16 well-known epigenetic clocks. These clocks estimate how old your cells act, separate from your birth certificate. The goal was simple: figure out which popular anti-aging interventions actually move the needle on these biological measurements, and which ones are just marketing noise.
The list of interventions tested reads like a longevity influencer’s wish list. Metformin, semaglutide, anti-inflammatory drugs, calorie restriction, intermittent fasting, Mediterranean and plant-based diets, exercise programs, and a pile of supplements all got checked against the data. That breadth matters. Instead of hyping one trendy pill, Yale compared dozens of approaches side by side using the same measurement tools.
Diet And Exercise Deliver, Supplements Mostly Disappoint
The clearest winner was boring and free: combine a healthy diet with regular exercise. Whether people followed Mediterranean, low-carb, or low-fat eating patterns, adding exercise on top consistently lowered epigenetic age readings. No single pill. No subscription box. Just food and movement, done together, over time.
Prescription drugs told a different story. Metformin, semaglutide, and anti-inflammatory treatments known as anti-TNF therapies showed the largest drops in biological-age markers among everything tested. These are not over-the-counter wellness products. They are regulated medications prescribed for diabetes, weight management, and inflammatory disease, which raises an obvious question about whether the anti-aging effect is separate from treating the underlying condition.
Supplements, the backbone of a massive wellness industry, largely came up empty. The available reporting describes little measurable effect from common over-the-counter products. That is a tough pill to swallow for an industry built on shelves of pills promising youth in a bottle.
Why This Study Still Comes With A Warning Label
Yale’s own researchers were careful not to oversell the findings. Changes in these biological markers do not prove someone will live longer or avoid age-related disease. The clocks measure a signal, not a guarantee. That distinction gets lost fast once headlines start talking about what “really” slows aging.
This caution lines up with broader scientific debate. Outside reviews of epigenetic clocks note that while these markers often predict disease and death in population studies, proving that changing the marker through treatment actually changes someone’s health outcome is a much higher bar, one that has not been cleared yet.
That gap between a promising lab signal and a proven treatment is exactly where common sense should kick in. Americans have been burned before by products that cite a study, skip the fine print, and sell certainty the science never claimed. This Yale work is a useful roadmap for future research, not a green light to start self-prescribing semaglutide or tossing out your gym membership for a supplement bottle.
The honest takeaway is refreshingly old-fashioned. Eat real food, move your body, and talk to a doctor before chasing prescription drugs for an off-label anti-aging effect. The flashiest claims in the wellness aisle still have the weakest evidence behind them, while the advice your grandmother gave you just got backed by a Yale research team.
Sources:
sciencedaily.com, medicine.yale.edu, news.yale.edu, ua.news, nature.com













